Table 1

Patient demographics, details of medication, and rejection episodes (n=12)

PatientSexAge at OLT (years)Reason for OLTImmunosuppression scheduleDuration of steroid treatment (months)Episodes of acute (chronic) rejectionFollow up (months)
1M53PSCTriple IM for 4/12 then  dual IM241 (1)24
2 F54AIHTriple IM 6018
3M48PSCTriple IM12224
4F48HaemochromatosisTriple IM14124
5F57AIHTriple IM14218
6F56PBCTriple IM18024
7M56PSCTriple IM for 3/12 then  dual IM242 (1)24
8F43AIHTriple IM for 3/12 then  dual IM18318
9M57Cryptogenic cirrhosisTriple IM 6112
10F51PBCTriple IM10224
11M51α1 Antitrypsin  deficiencyTriple IM12212
12F63PBCTriple IM 61 6
  • PBC, primary biliary cirrhosis; PSC, primary sclerosing cholangitis; AIH, autoimmune hepatitis; triple IM, immunosuppression with cyclosporin, azathioprine, and steroids; dual IM, immunosuppression with tacrolimus and steroids.